M-Ventures
M Ventures is the corporate venture capital fund of Merck KGaA, based in Darmstadt, Germany. Established in 2009, it focuses on investing in transformational ideas within the biotechnology and technology sectors. The fund operates with a dual mandate to achieve strategic alignment and financial returns for Merck, functioning as an "evergreen" fund that recycles proceeds from exits into new investments. Headquartered in Amsterdam, M Ventures has offices in Germany, the United States, and Israel, where it also runs an Israel Bioincubator to foster company creation from academic research. The fi
Investing activity
M-Ventures appears in 1 AI deal tracked by the AI Lounge deals desk, rounds totalling $65M. The rounds are mostly Series A, with a median round size of $65M. The most recent is Mueon (Series A, $65M, Oct 2026).
M-Ventures most often invests alongside Maverick Silicon, Geodesic Alliances Fund, Oregon Venture Fund and Intel Capital, and the companies it backs on AI Lounge are mostly in AI semiconductors / data center infrastructure.
Deals
Frequently asked questions about M-Ventures
What AI companies has M-Ventures invested in?
M-Ventures's AI investments include Mueon. The 1 round on AI Lounge are listed on this page with amounts, dates and co-investors.
Where is M-Ventures based?
M-Ventures is based in Amsterdam, North Holland, Netherlands.
What stage does M-Ventures invest at?
In the rounds tracked on AI Lounge, M-Ventures has invested at Series A, with a median round of $65M.
Who does M-Ventures co-invest with?
M-Ventures's most frequent co-investors on AI Lounge are Maverick Silicon (1 deal), Geodesic Alliances Fund (1 deal), Oregon Venture Fund (1 deal), Intel Capital (1 deal) and Wellington Capital (1 deal).
How can founders reach M-Ventures?
Founders on AI Lounge can see M-Ventures's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add M-Ventures to their Investor Pipeline to track the conversation.